Harmony Bioscien Rg
Harmony Biosciences Holdings, Inc. is a commercial‑stage biopharma focused on rare neurological disorders. Its marketed treatment, WAKIX, treats narcolepsy, while pitolisant and other agents—Phase 3 for Prader‑Willi and Fragile X—aim to tap high‑growth unmet markets.
Headquarters: United States (USA)
- Website: Visit Site 🔗
- Type: Corporation
Company Profile
- Sector: Professional Services
- Industry: Biotechnology Research
- Employees: 268
- HQ: Plymouth Meeting
Unlock the full potential.
Upgrade
Get access to Relative P/E Ratio Valuation Histogram.